SRPT vs the Top Picks average
| Pillar | SRPT | Book avg | Diff |
|---|---|---|---|
| Quality | 0.23 | 0.83 | -0.60 |
| Growth | 0.43 | 0.92 | -0.48 |
| Value | 0.71 | 0.75 | -0.04 |
Averaged across the 30 names in today's Top Picks (mean score 82.4). A name can beat these averages and still be absent from the book — it also applies concentration limits.
One point per daily model run. The range autoscales, so a flat-looking line can still hide 1–2 point moves — read the From → To values for the actual range.
Math only — share count is floor(portfolio × risk% ÷ (price × stop%)). Doesn't account for commissions, slippage, gap risk, or position-correlation across your book. Inputs persist locally; never sent to the server. Not investment advice.
Sarepta Therapeutics, Inc. (SRPT): score, valuation & FAQ
Sarepta Therapeutics, Inc. (SRPT) is a Biotechnology company that scores 41.2 out of 100 on the Bull Rankings quality-growth model — a below-average reading. The score blends three pillars — quality (durable returns, healthy margins, low leverage), growth (revenue and earnings), and value (valuation versus sector peers) — into one number, refreshed daily; it is a screen, not a buy recommendation.
Its strongest graded signals are P/S (A-), while FCF (C-) and Rev (F) rate weaker. On valuation, SRPT sits about 82% above our discounted-cash-flow fair value — the current price implies roughly 13% annual free-cash-flow growth over the next decade.
Is SRPT a good stock to buy?
Bull Rankings scores SRPT 41.2 out of 100 on its quality-growth model, which is a below-average reading. That is driven by P/S (A-). A score is a quantitative screen of Sarepta Therapeutics, Inc.'s fundamentals, not personalised financial advice — weigh it against your own time horizon and risk tolerance, and read the risk factors below before acting.
Why does SRPT score 41.2 on Bull Rankings?
The quality-growth score blends three pillars — quality (returns on capital, margins, leverage, earnings quality), growth (revenue and earnings expansion), and value (valuation versus sector peers). SRPT earns its highest marks on P/S (A-), and is held back by FCF (C-) and Rev (F). Each pillar is graded against sector-aware thresholds, then combined into the single 0–100 score.
Is SRPT overvalued or undervalued?
Based on $17.18, SRPT sits about 82% above our discounted-cash-flow fair value — the current price implies roughly 13% annual free-cash-flow growth over the next decade. Discounted-cash-flow estimates are sensitive to growth and discount-rate assumptions, so treat this as a cross-check, not a price target.
What are the main risks of investing in SRPT?
Revenue contracting -36% — the operational turn is not yet visible in the top line. Currently unprofitable (margin -9.8%) — path to GAAP profitability is the core thesis risk. Down 32% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up.
New to these metrics? The guides explain free cash flow, how the score works, and more in the learn hub — or run another name through the screener.
Bull Rankings is an automated fundamentals screen for research and education. It is not investment advice, and nothing here is a recommendation to buy or sell any security. Do your own research and consider consulting a licensed financial adviser.